Read publications that ECRIN has contributed to

Publications

The Global academic research organization network: Data sharing to cure diseases and enable learning health systems

Author(s)
Fukushima M, Austin C, Sato N, Maruyama T, Navarro E, Rocca M, Demotes J, Haendel M, Volchenboum SL, Cowperthwaite M, Silverstein JC.
Publication date
Journal reference
2019 Jan;3(1):e10073. Learning Health Systems. 2019 Jan;3(1):e10073.

How the new European data protection regulation affects clinical research and recommendations?

Author(s)
Demotes-Mainard J, Cornu C, Guérin A, Bertoye PH, Boidin R, Bureau S, Chrétien JM, Delval C, Deplanque D, Dubray C, Duchossoy L.
Publication date
Journal reference
Therapie. 2018 Dec 20.

Selecting Core Outcomes for Randomised Effectiveness trials In Type 2 Diabetes (SCORE-IT): study protocol for the development of a core outcome set

Author(s)
Harman NL, Wilding J, Curry D, Harris J, Logue J, Pemberton RJ, Perreault L, Thompson G, Tunis S, Williamson PR
Publication date
Journal reference
Trials. 2018 Dec;19(1):427.

Quel impact du nouveau règlement européen sur la protection des données sur la recherche clinique et recommandations

Author(s)
Demotes-Mainard J, Cornu C, Guérin A, Bertoye PH, Boidin R, Bureau S, Chrétien JM, Delval C, Deplanque D, Dubray C, Duchossoy L.
Publication date
Journal reference
Thérapie. 2018 Nov 30.

Rationale and design of a multicentre, randomized, placebo‐controlled trial of mirabegron, a Beta3‐adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease Beta3‐left ventricular hypertrophy

Author(s)
Pouleur AC, Anker S, Brito D, Brosteanu O, Hasenclever D, Casadei B, Edelmann F, Filippatos G, Gruson D, Ikonomidis I, Lhommel R, Mahmod M, Neubauer S, Persu A, Gerber BL, Piechnik S, Pieske B, Pieske-Kraigher E, Pinto F, Ponikowski P, Senni M, Trochu JN, Van Overstraeten N, Wachter R, Balligand JL.
Publication date
Journal reference
ESC Heart Fail. 2018 Oct;5(5):830-841. doi: 10.1002/ehf2.12306. Epub 2018 Jun 22.

PRECIOUS: PREvention of Complications to Improve OUtcome in elderly patients with acute Stroke. Rationale and design of a randomised, open, phase III, clinical trial with blinded outcome assessment

Author(s)
Reinink H, de Jonge JC, Bath PM, van de Beek D, Berge E, Borregaard S, Ciccone A, Csiba L, Demotes J, Dippel DW, Kõrv J
Publication date
Journal reference
European stroke journal. 2018 Sep;3(3):291-8.

Involving children and young people in clinical research through the forum of a European Young Persons’ Advisory Group: needs and challenges.

Author(s)
Gaillard S, Malik S, Preston J, Escalera BN, Dicks P, Touil N, Mardirossian S, Claverol‐Torres J, Kassaï B.Fundamental & clinical pharmacology.
Publication date
Journal reference
2018 Aug;32(4):357-62.

Classification of processes involved in sharing individual participant data from clinical trials

Author(s)
Ohmann C, Canham S, Banzi R, Kuchinke W, Battaglia S.
Publication date
Journal reference
F1000Research. 2018;7.

Orchestrating differential data access for translational research: a pilot implementation

Author(s)
Brandizi M, Melnichuk O, Bild R, Kohlmayer F, Rodriguez-Castro B, Spengler H, Kuhn KA, Kuchinke W, Ohmann C, Mustonen T, Linden M.
Publication date
Journal reference
BMC medical informatics and decision making. 2017 Dec;17(1):30.

SCORE-IT (Selecting Core Outcomes for Randomised Effectiveness trials In Type 2 diabetes): a systematic review of registered trials.

Author(s)
Harman NL, James R, Wilding J, Williamson PR; Battaglia S, Demotes-Mainard J, Gailus-Durner V, Garattini S, Prinsen CAC, Raess M, da Silva-Buttkus P, Terwee CB.
Publication date
Journal reference
Trials. 2017 Dec;18(1):597.